Birchview Capital, LP’s Acceleron Pharma Inc Position
Does Birchview Capital, LP own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 10.7K shares worth $2M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q3 2021
Shares
10.7K
% of Portfolio
+1.25%
Quarters Held
12
position exited
Position History XLRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2021 | 10.7K | $2M | +1.25% |
| Q2 2021 | 18.7K | $2M | +1.40% |
| Q1 2021 | 18.7K | $3M | +1.50% |
| Q4 2020 | 18.7K | $2M | +1.38% |
| Q3 2020 | 18.7K | $2M | +1.40% |
| Q2 2020 | 18.7K | $2M | +1.08% |
| Q1 2020 | 18.7K | $2M | +1.49% |
| Q4 2019 | 18.7K | $990,000 | +0.72% |
| Q3 2019 | 18.7K | $738,000 | +0.49% |
| Q2 2019 | 18.7K | $767,000 | +0.47% |
| Q1 2019 | 18.7K | $870,000 | +0.55% |
| Q4 2018 | 18.7K | $813,000 | +0.77% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of XLRN.